Uni-Bio Science Group Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Uni-Bio Science Group Limited with three other
companies in this sector in Hong Kong:
OCI International Holdings Ltd
sales of 124.61 million Hong Kong Dollars [US$15.92 million]
of which 42%
was Asset Management),
Hao Wen Holdings Limited
(88.40 million Hong Kong Dollars [US$11.29 million]
of which 55%
was Electronic parts), and
Extrawell Pharmaceutical Holdings Limited
(85.76 million Hong Kong Dollars [US$10.96 million]
of which 70%
Uni-Bio Science Group Limited reported sales of HK$135.26 million (US$17.28 million)
December of 2018.
decrease of 13.6%
versus 2017, when the company's sales were HK$156.48 million.
Contributing to the drop in overall sales was the 54.5% decline
in In-House Chemical Pharmaceutical Products, from HK$69.19 million to HK$31.51 million.
However, these declines were partially offset by the increase in sales of
In-House Biological Pharmaceutical Produ (up 18.9% to HK$103.75 million)